특허 및 논문

Intellectual Property (cont.)

13 Jung, H.-S., and Lee, S.-W. (2005) Re-engineering of carcinoembryonic antigen RNA with the group I intron of Tetrahymena thermophila by targeted trans-splicing. Journal of Microbiology and Biotechnology 15: 1408-1413.
12 Kwon, B.-S., Jung, H.-S., Song, M.-S., Cho, K. S., Kim, S.-C.. Kimm, K., Jeong, J. S., Kim, I.-H., and Lee, S.-W. (2005). Specific Regression of Human Cancer Cells by Ribozyme-Mediated Targeted Replacement of Tumor-Specific Transcript. Molecular Therapy 1
11 Jung, H.-S., Kwon, B.-S., and Lee, S.-W. (2005) Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron. Biotechnology Letters 27: 567-574.
10 Ryu, K.-J., and Lee, S.-W. (2004) Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site. The Journal of Microbiology 42: 361-364.
9 Shin, K.-S., Sullenger, B. A., and Lee, S.-W. (2004) Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA. Molecular Therapy. 10: 365-372.
8 Park, Y.-H., Jung, H.-S., Kwon, B.-S., and Lee, S.-W. (2003). Replacement of thymidine phosphorylase RNA with group I intron of Tetrahymena thermophila by targeted trans-splicing. The Journal of Microbiology 41: 340-344.
7 Ryu, K.-J., and Lee, S.-W. (2003) Identification of most accessible sites to ribozymes on hepatitis C virus internal ribosome entry site. Journal of Biochemistry and Molecular Biology 36: 538-544.
6 Ryu, K.-J., Kim, J.-H., and Lee, S.-W. (2003). Ribozyme-Mediated Selective Induction of New Gene Activity in Hepatitis C Virus Internal Ribosome Entry Site-Expressing Cells by Targeted Trans-Splicing. Molecular Therapy 7: 386-395.
5 Shin, K.-S., Bae, S.-J., Hwang, E.-S., Jeong, S., and Lee, S.-W. (2002). Ribozyme-mediated replacement of p53 RNA by targeted trans-splicing. Journal of Microbiology and Biotechnology 12: 844-848.
4 Lan, N., Rooney, B. L., Lee, S.-W., Howrey, R. P., Smith, C. A., and Sullenger, B. A. (2000). Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Molecular Therapy 2: 245-255.